1. Home
  2. NXST vs TNGX Comparison

NXST vs TNGX Comparison

Compare NXST & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexstar Media Group Inc.

NXST

Nexstar Media Group Inc.

N/A

Current Price

$186.48

Market Cap

5.4B

Sector

Industrials

ML Signal

N/A

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

N/A

Current Price

$27.08

Market Cap

4.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NXST
TNGX
Founded
1996
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
4.5B
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
NXST
TNGX
Price
$186.48
$27.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
10
Target Price
$263.75
$21.78
AVG Volume (30 Days)
378.4K
2.7M
Earning Date
05-07-2026
05-08-2026
Dividend Yield
3.67%
N/A
EPS Growth
N/A
26.89
EPS
5.09
N/A
Revenue
$4,949,000,000.00
$62,384,000.00
Revenue This Year
$11.38
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$36.01
N/A
Revenue Growth
N/A
48.29
52 Week Low
$154.47
$5.60
52 Week High
$254.30
$34.39

Technical Indicators

Market Signals
Indicator
NXST
TNGX
Relative Strength Index (RSI) 59.96 44.84
Support Level $177.36 $19.74
Resistance Level $191.30 $28.41
Average True Range (ATR) 6.10 1.76
MACD 0.95 -0.50
Stochastic Oscillator 72.64 10.98

Price Performance

Historical Comparison
NXST
TNGX

About NXST Nexstar Media Group Inc.

Nexstar is the largest television station owner-operator in the United States with over 200 stations in 116 markets, reaching 220 million people. Of its 200 stations, 155 are affiliated with the four national broadcast networks: CBS, Fox, NBC, and ABC. Assuming its merger with Tegna is affirmed Nexstar's station total would exceed 259 and reach 80% of the US population. Nexstar also owns NewsNation (formerly WGN), a cable news network, 75% of the fifth national broadcaster, the CW, and a 31% stake in Food Network and Cooking Channel.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: